Vet Med - Czech, 2014, 59(6):307-314 | DOI: 10.17221/7575-VETMED

Interaction of CB1 receptor agonist arachidonylcyclopropylamide with behavioural sensitisation to morphine in miceOriginal Paper

L. Landa1,3, K. Slais3, A. Machalova2,3, A. Sulcova2
1 University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic
2 CEITEC - Central European Institute of Technology, Masaryk University, Brno, Czech Republic
3 Faculty of Medicine, Masaryk University, Brno, Czech Republic

Activities of the endocannabinoid system are believed to be substantially involved in psychostimulant and opioid addiction. Nevertheless, interactions between cannabinoid and opioid systems are not yet fully understood. Thus, the aim of the present study was to investigate the interaction between morphine and the cannabinoid CB1 receptor agonist arachidonylcyclopropylamide (ACPA) in behavioural sensitisation. Sensitisation occurs after repeated exposure to drugs of abuse including morphine and cannabinomimetics and it has been suggested to mediate craving and relapses. Male mice were randomly allocated into three groups and were seven times (from the 7th to 13th day of the experiment) administered drugs as follows: (a) n1: vehicle at the dose of 10 ml/kg/day; (b) n2: morphine at the dose of 10.0 mg/kg/day; (c) n3: ACPA at the dose of 1.0 mg/kg/day. Changes in locomotor behaviour were measured in the Open Field Test: (a) after administration of vehicle on the 1st experimental day, (b) after the 1st dose of drugs given on the 7th day, and (c) on the 14th day after "challenge doses" given in the following way: n1: saline at the dose of 10 ml/kg, n2, 3: morphine at the dose of 10.0 mg/kg. Registered behavioural changes unambiguously showed the development of behavioural sensitisation to the stimulatory effects of morphine on locomotion after its repeated administration (P < 0.05). However, surprisingly, taking into account reports on synergistic effects of opioids and cannabinoid receptor stimulation, a significant decrease (P < 0.05) in behavioural sensitisation to morphine occurred when the drug challenge dose was given following repeated pre-treatment with the CB1 receptor agonist ACPA, i.e. suppression of cross-sensitisation to morphine.

Keywords: behavioural sensitisation; morphine; cannabinoids; ACPA; mice

Published: June 30, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Landa L, Slais K, Machalova A, Sulcova A. Interaction of CB1 receptor agonist arachidonylcyclopropylamide with behavioural sensitisation to morphine in mice. Vet Med - Czech. 2014;59(6):307-314. doi: 10.17221/7575-VETMED.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Azizi P, Haghparast A, Hassanpour-Ezatti M (2009): Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behavioural Brain Research 197, 119-124. Go to original source... Go to PubMed...
    2. Bahi A, Dreyer JL (2012): Involvement of nucleus accumbens dopamine D1 receptors in ethanol drinking, ethanol-induced conditioned place preference, and ethanol-induced psychomotor sensitization in mice. Psychopharmacology 222, 141-153. Go to original source... Go to PubMed...
    3. Bosier B, Sarre S, Smolders I, Michotte Y, Hermans E, Lambert DM (2010): Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists. Neuropharmacology 59, 503-510. Go to original source... Go to PubMed...
    4. Braida D, Limonta V, Capurro V, Fadda P, Rubino T, Mascia P, Zani A, Gori E, Fratta W, Parolaro D, Sala M (2008): Involvement of κ-opioid and endocannabinoid system on salvinorin a-induced reward. Biological Psychiatry 63, 286-292. Go to original source... Go to PubMed...
    5. Cadoni C, Pisanu A, Solinas M, Acquas E, Di Chiara G (2001): Behavioural sensitization after repeated exposure to Δ9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology 158, 259-266. Go to original source... Go to PubMed...
    6. Cadoni C. Valentini V, Di Chiara G (2008): Behavioral sensitization to Delta(9)-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. Journal of Neurochemistry 106, 1586-1593. Go to original source... Go to PubMed...
    7. Coelhoso CC, Engelke DS, Filev R, Silveira DX, Mello LE, Santos JG (2013): Temporal and behavioral variability in cannabinoid receptor expression in outbred mice submitted to ethanol-induced locomotor sensitization paradigm. Alcoholism - Clinical and Experimental Research 37, 1516-1526. Go to original source... Go to PubMed...
    8. Contet C, Filliol D, Matifas A, Kieffer BL (2008): Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity. Neuropharmacology 54, 475-486. Go to original source... Go to PubMed...
    9. De Vries TJ, Schoffelmeer AN, Binnekade R, Raaso H, Vanderschuren LJ (2002): Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 26, 18-26. Go to original source... Go to PubMed...
    10. Enman NM, Unterwald EM (2012): Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse. Behavioural Brain Research 231, 217-225. Go to original source... Go to PubMed...
    11. Farahmandfar M, Zarrindast MR, Kadivar M, Karimian SM, Naghdi N (2011a): The effect of morphine sensitization on extracellular concentrations of GABA in dorsal hippocampus of male rats. European Journal of Pharmacology 669, 66-70. Go to original source... Go to PubMed...
    12. Farahmandfar M, Karimian SM, Zarrindast MR, Kadivar M, Afrouzi H, Naghdi N (2011b): Morphine sensitization increases the extracellular level of glutamate in CA1 of rat hippocampus via mu-opioid receptor. Neuroscience Letters 494, 130-134. Go to original source... Go to PubMed...
    13. Gonzalez S, Cebeira M, Fernandez-Ruiz J (2005): Cannabinoid tolerance and dependence: A review of studies in laboratory animals. Pharmacology Biochemistry and Behavior 81, 300-318. Go to original source... Go to PubMed...
    14. Haghparast A, Azizi P, Hassanpour-Ezatti M, Khorrami H, Naderi N (2009): Sub-chronic administration of AM251, CB1 receptor antagonist, within the nucleus accumbens induced sensitisation to morphine in the rat. Neuroscience Letters 467, 43-47. Go to original source... Go to PubMed...
    15. Hagues G, Costentin J, Duterte-Boucher D (2007): Modulation of morphine and alcohol motor stimulant effects by cannabinoid receptors ligands. Behavioural Brain Research 178, 274-282. Go to original source... Go to PubMed...
    16. Herrera AS, Casanova JP, Gatica RI, Escobar F, Fuentealba JA (2013): Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization. Progress in Neuropsychpharmacology & Biological Psychiatry 47, 1-6. Go to original source... Go to PubMed...
    17. Hofford RS, Schul DL, Wellman PJ, Eitan S (2012): Social influences on morphine sensitization in adolescent rats. Addiction Biology 17, 547-556. Go to original source... Go to PubMed...
    18. Hu Z, Lee CI, Han JY, Oh EH, Ryu JH, Hong JT, Kim Y, Oh KW (2014): Caffeine induces behavioural sensitization and overexpression of cocaine-regulated and amphetamine-regulated transcript peptides in mice. Behavioural Pharmacology 25, 32-43. Go to original source... Go to PubMed...
    19. Hutchinson AJ, Ma JS, Liu JB, Hudson RL, Dubocovich ML (2014): Role of MT1 melatonin receptors in methamphetamine-induced locomotor sensitization in C57BL/6 mice. Psychopharmacology 231, 257-267. Go to original source... Go to PubMed...
    20. Jardinaud F, Roques BP, Noble F (2006): Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice. Behavioural Brain Research 173, 255-261. Go to original source... Go to PubMed...
    21. Jing L, Zhang M, Li JX, Huang P, Liu Q, Li YL, Liang H, Liang JH (2014): Comparison of single versus repeated methamphetamine injection induced behavioral sensitization in mice. Neuroscience Letters 560, 103-106. Go to original source... Go to PubMed...
    22. Katsidoni V, Kastellakis A, Panagis G (2013): Biphasic effects of Delta(9)-tetrahydrocannabinol on brain stimulation reward and motor activity. International Journal of Neuropsychopharmacology 16, 2273-2284. Go to original source... Go to PubMed...
    23. Keeney BK, Meek TH, Middleton KM, Holness LF, Garland T (2012): Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred for high voluntary wheel-running behavior. Pharmacology Biochemistry and Behavior 101, 528-537. Go to original source... Go to PubMed...
    24. Lamarque S, Taghzouti K, Simon H (2001): Chronic treatment with Delta(9) - tetrahydrocannabinol enhances the locomotor response to amphetamine and heroin. Implications for vulnerability to drug addiction. Neuropharmacology 41, 118-129. Go to original source... Go to PubMed...
    25. Landa L, Slais K, Sulcova A (2006): Involvement of cannabinoid CB1 and CB2 receptor activity in the development of behavioural sensitization to methamphetamine effects in mice. Neuroendocrinology Letters 27, 63-69. Go to PubMed...
    26. Landa L, Jurajda M, Sulcova A (2011): Altered cannabinoid CB1 receptor mRNA expression in mesencephalon from mice exposed to repeated methamphetamine and methanandamide treatments. Neuroendocrinology Letters 32, 841-846. Go to PubMed...
    27. Landa L, Machalova A, Sulcova A (2014a): Implication of N-methyl-D-aspartate mechanisms in behavioural sensitization to psychostimulants: a short review. European Journal of Pharmacology 730, 77-81. Go to original source... Go to PubMed...
    28. Landa L, Slais K, Machalova A, Sulcova A (2014b): The effect of cannabinoid CB1 receptor agonist arachidonylcyclopropylamide (ACPA) on behavioural sensitisation to methamphetamine in mice. Veterinarni Medicina 59, 88-94. Go to original source...
    29. Lee B, Park J, Kwon S, Yeom M, Sur B, Shim I, Lee H, Yoon SH, Jeong DM, Hahm DH (2012): Inhibitory effect of sowthistle (Ixeris dentata) on development and expression of behavioral locomotor sensitization to nicotine in rats. Food Science and Biotechnology 21, 723-729. Go to original source...
    30. Lopez-Moreno JA, Lopez-Jimenez A, Gorriti MA, de Fonseca FR (2010): Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors. Current Drug Targets 11, 406-428. Go to original source... Go to PubMed...
    31. Manzanedo C, Aguilar MA, Rodriguez-Arias M, Navarro M, Minarro J (2004): Cannabinoid agonist-induced sensitisation to morphine place preference in mice. Neuroreport 15, 1373-1377. Go to original source... Go to PubMed...
    32. Nestler EJ (2001): Molecular basis of long-term plasticity underlying addiction. Nature Reviews Neuroscience 2, 119-128. Go to original source... Go to PubMed...
    33. Norwood CS, Cornish JL, Mallet PE, McGregor IS (2003): Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitisationand alters morphine self-administration in Lewis rats. European Journal of Pharmacology 465, 105-114. Go to original source... Go to PubMed...
    34. Parolaro D, Rubino T, Vigano D, Massi P, Guidali C, Realini N (2010): Cellular mechanisms underlying the interaction between cannabinoid and opioid system. Current Drug Targets 11, 393-405. Go to original source... Go to PubMed...
    35. Rey AA, Purrio M, Viveros MP, Lutz B (2012): Biphasic effects of cannabinoids in anxiety responses: CB1 and GABA(B) receptors in the balance of GABAergic and glutamatergic neurotransmission. Neuropsychopharmacology 37, 2624-2634. Go to original source... Go to PubMed...
    36. Rezayof A, Sardari M, Zarrindast MR, Nayer-Nouri T (2011): Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference. Behavioural Brain Research 220, 1-8. Go to original source... Go to PubMed...
    37. Robledo P, Berrendero F, Ozaita A, Maldonado R (2008): Advances in the field of cannabinoid-opioid cross-talk. Addiction Biology 13, 213-224. Go to original source... Go to PubMed...
    38. Rubino T, Vigano, Massi P, Parolaro D (2001): The psychoactive ingredient of marijuana induces behavioural sensitization. European Journal of Neuroscience 14, 884-886. Go to original source... Go to PubMed...
    39. Rubino T, Vigano D, Massi P, Parolaro D (2003): Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization. European Journal of Neuroscience 17, 325-330. Go to original source... Go to PubMed...
    40. Scavone JL, Sterling RC, Van Bockstaele EJ (2013): Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal. Neuroscience 248, 637-654. Go to original source... Go to PubMed...
    41. Serrano A, Aguilar MA, Manzanedo C, Rodriguez-Arias M, Minarro J (2002): Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry 26, 1263-1271. Go to original source... Go to PubMed...
    42. Singh ME, Verty ANA, McGregor IS, Mallet PE (2004): A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitisationto morphine. Brain Research 1026, 244-253. Go to original source... Go to PubMed...
    43. Singh ME, McGregor IS, Naplet PE (2005): Repeated exposure to Δ9-tetrahydrocannabinol alters heroininduced locomotor sensitisation and Fos-immunoreactivity. Neuropharmacology 49, 1189-1200. Go to original source... Go to PubMed...
    44. Slamberova R, Yamamotova A, Schutova B, Hruba L, Pometlova M (2011): Impact of Prenatal Methamphetamine Exposure on the Sensitivity to the Same Drug in Adult Male Rats. Prague Medical Report 112, 102-114. Go to PubMed...
    45. Sulcova A, Mechoulam R, Fride E (1998): Biophasic Effects of Anandamide. Pharmacology Biochemistry and Behavior 59, 347-352. Go to original source... Go to PubMed...
    46. Sulcova A, Landa L, Slais K (2004): Sensitization and cannabinoid cross-sensitization to methamphetamine antiaggressive effects is not developed in morphine treatment design in mice. Fundamental & Clinical Pharmacology 18, Suppl.1, 58.
    47. Vanderschuren LJMJ, Kalivas PW (2000): Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology 151, 99-120. Go to original source... Go to PubMed...
    48. Valverde O, Noble F, Beslot F, Dauge V, Fournie-Zaluski MC, Roques BP (2001): Δ9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. European Journal of Neuroscience 13, 1816-1824. Go to original source... Go to PubMed...
    49. Vassoler FM, Johnson NL, Byrnes EM (2013): Female adolescent exposure to cannabinoids causes transgenerational effects on morphine sensitisation in female offspring in the absence of in utero exposure. Journal of Psychopharmacology 27, 1015-1022. Go to original source... Go to PubMed...
    50. Vigano D, Valenti M, Cascio MG, Di Marzo V, Parolaro D, Rubino T (2004): Changes in endocannabinoid levels in a rat model of behavioural sensitisation to morphine. European Journal of Neuroscience 20, 1849-1857. Go to original source... Go to PubMed...
    51. Zarrindast MR, Heidari-Darvishani A, Rezayof A, FathiAzarbaijani F, Jafari-Sabet M, Hajizadeh-Moghaddam A (2007): Morphine-induced sensitization in mice: changes in locomotor activity by prior scheduled exposure to GABA(A) receptor agents. Behavioural Pharmacology 18, 303-310. Go to original source... Go to PubMed...
    52. Zarrindast MR, Sarahroodi S, Arzi A, Khodayar MJ, Taheri-Shalmani S, Rezayof A (2008): Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Behavioural Pharmacology 19, 716-723. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content